Latest Pacira Pharmaceuticals Inc. Stories

2014-09-29 08:32:11

NEW YORK, Sept. 29, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Pacira Pharmaceuticals, Inc. ("Pacira" or the "Company") (NasdaqGS: PCRX). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484. The investigation focuses on whether the Company and certain of its executives...

2014-09-25 16:25:59

NEW YORK, Sept. 25, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pacira Pharmaceuticals, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether Pacira and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On September 25, 2014, the...

2014-02-21 23:03:17

National Patient Safety Foundation Program Aligns Stakeholders from Across Health Care in a Unifying Mission Boston, MA (PRWEB) February 21, 2014 The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, is pleased to announce that Pacira Pharmaceuticals, Inc., has joined the NPSF Patient Safety Coalition as an associate member. Pacira, located in New Jersey and California, is a specialty pharmaceutical company focused on the development of new products...

2012-10-13 04:04:32

IMPROVE trial compares the cost of care between a standard opioid-based regimen and an EXPAREL-based multimodal regimen for postsurgical pain management. Online (PRWEB) October 11, 2012 PARSIPPANY, N.J.-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced topline results from the first completed IMPROVE study in its prospective Phase 4 clinical program. The study was designed to compare the difference in three primary endpoints–cost, opioid consumption and hospital length of...

Word of the Day
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.